Viemed Healthcare Inc VMD

Management additions

[ol_griz]

Very encouraging development. A confident, growing company and one that acknowledges that its management needs expansion and additional expertise (Are you listening over at GSI, Mr. Dyment?).  I like the timing.

[LongTerm3]

These guys left a growing profitable company with a market cap of over 5 Billion for Viemed, with a market cap of 300 million.  This tells you what they must see in Viemed's future growth. They did almost 2 Billion in acquisitions. My gut feeling is they are ready to start acquiring companies, which they have mentioned on previous calls. We should hear more on Wednesday's call.

[lscfa]

Hoyt has always maintained acquisitions of vent co.s are not economic so this must mean Viemed is diversifying to other areas like the oxygen biz it has been building. Does this mean the biz model of RTs working out of the trunk of their car is also on the way out? Mgmt needs to expand on this in the next CC.

[LongTerm3]

He said acquisitions of vents at certain prices was not worth it. They will not over pay. You are trying to change the whole company. Nothing is changing, only more growth. Please just state facts.

[lscfa]

Do more dd, you dope.    Hoyt says acquiring co.s doing the same thing as Viemed is uneconomic becasue you are simply buying patients that die in 12 months. Viemed acquistions will be focused on co.s that sell things other than vents that can be crosssold to its vent patients.   

[LongTerm3]

Nice response!

[besttobe]

Sounds like the core revenue organic growth has slowed to the point, where they need to do aquisitions for meaningful growth. Not sure the market will think this news a good thing. More clarification is required.  Hopefully ISFCA is correct, that they will be buying business other than the NIV. Hoyt did say, buying NIV revenue is not worth it, as you are only buying 12 month revenue, because

[JackLambert]

Sure.  Just hit $8 US premarket.